You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 59651-0152


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 59651-0152

Drug NameNDCPrice/Unit ($)UnitDate
PROGESTERONE 100 MG CAPSULE 59651-0152-01 0.25973 EACH 2025-03-19
PROGESTERONE 100 MG CAPSULE 59651-0152-01 0.24029 EACH 2025-02-19
PROGESTERONE 100 MG CAPSULE 59651-0152-01 0.21680 EACH 2025-01-22
PROGESTERONE 100 MG CAPSULE 59651-0152-01 0.21062 EACH 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 59651-0152

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Prescription Drugs: A Focus on NDC 59651-152

Introduction

The pharmaceutical market is a complex and dynamic sector, influenced by various factors such as new drug approvals, patent expirations, and regulatory policies. This article will delve into the market analysis and price projections for prescription drugs, with a specific focus on the drug identified by the NDC code 59651-152, which corresponds to Progesterone capsules.

Overview of the Pharmaceutical Market

The pharmaceutical market in the United States has seen significant growth in recent years. In 2023, overall pharmaceutical expenditures in the US grew by 13.6% compared to 2022, reaching a total of $722.5 billion. This growth was driven by increased utilization, new drug approvals, and price increases[2].

Factors Influencing Drug Prices

Several factors contribute to the fluctuations in drug prices:

Utilization and Demand

Increased utilization of drugs, particularly in clinics, has been a key driver of expenditure growth. For instance, in clinics, increased utilization drove a 15.0% increase in expenditures in 2023[2].

New Drug Approvals

New drug approvals can significantly impact the market. In 2024, several new drugs are expected to be approved, which will influence spending, especially in the areas of specialty, endocrine, and cancer drugs[2].

Price Increases

Drug manufacturers frequently adjust list prices, with many increases exceeding the rate of inflation. From January 2022 to January 2023, over 4,200 drug products had price increases, with an average increase of 15.2%[3].

Regulatory Policies

Policies and legislation can also affect drug prices. For example, inflation rebates under Medicare Part B and Part D can impact pricing strategies for drug manufacturers[3].

Market Performance of Non-Traditional Models

Non-traditional models, such as those operated by Civica, have been gaining traction. Between 2020 and 2022, these models sold 350.2 million units of drugs, representing 1.7% of the total sales and volume for those drugs. The average sales price for these drugs varied over time but generally aligned with or were lower than those of traditional models by the end of the period[1].

Price Trends for Prescription Drugs

Historical Price Changes

From 2017 to 2023, the list prices of prescription drugs have seen significant changes. The average price increase from January 2022 to January 2023 was 15.2%, translating to a $590 increase per drug product. This trend indicates that price increases are concentrated in more expensive drug products, leading to higher dollar value increases[3].

Seasonal Patterns

Price increases tend to cluster around specific times of the year, with the largest number of increases occurring in January and the second largest in July[3].

Specific Analysis for Progesterone Capsules (NDC 59651-152)

Market Position

Progesterone capsules, marketed by Aurobindo Pharma Limited, are used to treat various conditions, including menopausal symptoms and as part of hormone replacement therapy. The market for these capsules is part of the broader hormonal therapy segment.

Price Projections

Given the general trends in the pharmaceutical market:

  • Utilization and Demand: If the demand for hormonal therapies remains stable or increases, it could support higher sales volumes for Progesterone capsules.
  • Price Increases: Following the trend of average price increases exceeding inflation, it is likely that the list price of Progesterone capsules could see an increase. For multi-source drugs like Progesterone, the average price increase might be higher than for single-source drugs[3].

Example Price Increase Scenario

If we consider the average price increase of 15.2% observed from January 2022 to January 2023, a similar increase could be projected for Progesterone capsules. For instance, if the current list price is around $10 per unit, a 15.2% increase would result in a new list price of approximately $11.52 per unit.

Impact of Regulatory and Market Factors

Inflation Rebates

Regulatory measures such as inflation rebates under Medicare Part B and Part D could influence pricing strategies. Manufacturers might adjust list prices to account for these rebates, potentially affecting the net price paid by consumers and payers[3].

New Policies and Legislation

Any new policies or legislation aimed at controlling drug prices could impact the market dynamics. For example, policies that cap price increases or mandate transparency in pricing could affect the future price trajectory of Progesterone capsules.

Conclusion

The pharmaceutical market is highly dynamic, with multiple factors influencing drug prices. For Progesterone capsules (NDC 59651-152), the likelihood of price increases aligns with broader market trends. Here are some key takeaways:

  • Price Increases: Expect potential price increases exceeding the rate of inflation.
  • Market Demand: Stable or increasing demand for hormonal therapies could support higher sales volumes.
  • Regulatory Impact: Inflation rebates and new policies could influence pricing strategies.

Key Takeaways

  • The pharmaceutical market saw a 13.6% growth in expenditures in 2023.
  • Drug prices are influenced by utilization, new drug approvals, and regulatory policies.
  • Non-traditional models are gaining traction but still represent a small fraction of the market.
  • Price increases for prescription drugs often exceed the rate of inflation.
  • Progesterone capsules are likely to see price increases following general market trends.

FAQs

What are the main drivers of pharmaceutical expenditure growth?

The main drivers include increased utilization, new drug approvals, and price increases.

How do non-traditional models like Civica impact the pharmaceutical market?

Non-traditional models have increased production and sales, though they still represent a small fraction of the total market. They often have competitive pricing and can influence market dynamics.

What is the trend in list price changes for prescription drugs?

List prices often increase, with many increases exceeding the rate of inflation. The largest number of price increases typically occurs in January and July.

How might regulatory policies affect drug prices?

Regulatory policies such as inflation rebates and legislation aimed at controlling prices can influence manufacturers' pricing strategies and the net prices paid by consumers and payers.

What can be expected for the price of Progesterone capsules in the future?

Given the general trend, it is likely that the price of Progesterone capsules will increase, potentially exceeding the rate of inflation.

Sources

  1. ASPE. SDP Nonprofit Quantitative Issue Brief. July 2024.
  2. PubMed. National trends in prescription drug expenditures and projections for 2024. July 2024.
  3. ASPE. Changes in the List Prices of Prescription Drugs, 2017-2023. October 2023.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.